top of page



First FDA-Approved, Cellular Therapy
to Treat Type 1 Diabetes

Lantidra™ (donislecel) is a breakthrough treatment approved for adults with type 1 diabetes (T1D) who experience severe hypoglycemia despite intensive diabetes management and education. Lantidra is the first FDA-approved allogeneic cellular therapy made from donor pancreatic islet cells for the treatment of T1D.

Why Lantidra ?

Proven Safety and Efficacy

The safety and effectiveness of Lantidra in subjects with type 1 diabetes and hypoglycemic unawareness was demonstrated in two clinical trials involving a combined 30 subjects, all of whom received at least one islet infusion and a maximum of three infusions. Both trials were prospective, open-label, single-arm studies. The most common side effects or adverse reactions are related to the need for immunosuppressive medications to maintain islet cell viability.

READ MORE…. Clinical Data in Package Insert

High Quality Pancreatic Islets

Quality control (QC) assessments are performed to confirm potency (functionality) and sterility of isolated islets. QC testing is performed in compliance with rigorous FDA standards. Release criteria are verified before approval of each Lantidra lot for transplantation. CellTrans, Inc. is the manufacturer of Lantidra.

READ MORE…. Product Information

Partnership with
University of Illinois Hospital (UIH)

Our current main healthcare institution partnership is with the University of Illinois Hospital (UIH) located in Chicago, IL. UIH is comprised of highly-skilled transplant surgeons and physicians to ensure the best clinical outcomes after administration of Lantidra.


Insurance Coverage Options

Lantidra is an FDA approved cell therapy to treat type 1 diabetes. FDA approved treatments may qualify for medical insurance coverage and reimbursement. 

About Lantidra

At CellTrans, we are dedicated to providing innovative treatment options for adults with type 1 diabetes. Our unique approach is designed to help patients who experience severe hypoglycemia despite intensive diabetes management.

Looking in microscope in facility-EDITED-1920.jpg

Innovative Cell Therapy

Our interdisciplinary  team of leading scientists, engineers, and physicians is committed to advancing the field of cell therapy for type 1 diabetes. Lantidra is the first FDA approved therapy to treat type 1 diabetic patients.

Patient Testimonials

“I’ve been off of insulin for 16 years now.”

bottom of page